National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 5190 [2013-01327]
Download as PDF
<![CDATA[
5190
Federal Register / Vol. 78, No. 16 / Thursday, January 24, 2013 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
National Cancer Institute; Amended
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
Advisory Neurological Disorders and
Stroke.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Neurological
Disorders and Stroke, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: February 24–26, 2013.
Time: 7:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Alan P. Koretsky, Ph.D.,
Scientific Director, Division of Intramural
Research, National Institute of Neurological
Disorders and Stroke, NIH, 35 Convent Drive,
Room 6A908, Bethesda, MD 20892, (301)
435–2232, koretskya@ninds.nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: January 17, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–01327 Filed 1–23–13; 8:45 am]
erowe on DSK2VPTVN1PROD with
BILLING CODE 4140–01–P
VerDate Mar<15>2010
15:12 Jan 23, 2013
Jkt 229001
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, March
7, 2013, 12:00 p.m. to March 7, 2013,
4:00 p.m., National Institutes of Health,
6116 Executive Boulevard, Rockville,
MD, 20852 which was published in the
Federal Register on December 7, 2012,
77 FR 73036.
This notice is being amended to
change the location, date and time to
Hilton Washington DC North, 620 Perry
Parkway, Gaithersburg, MD 20877,
March 25, 2013, 8:00 a.m.–5:00 p.m.
Additionally, the meeting is being held
as a face-to-face meeting. The meeting is
closed to the public.
Dated: January 17, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–01331 Filed 1–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Clinical Trials
and Translational Research Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee; Ad hoc
Clinical Trials and Strategic Planning
Subcommittee.
Date: February 25, 2013.
Time: 5:00 p.m. to 6:00 p.m.
Agenda: Update on the NCI National
Clinical Trials Network (NCTN) Working
Group of the Ad hoc Clinical Trials Strategic
Planning Subcommittee. Dial in number: 1–
866–652–9542 and Passcode: 4596704.
Place: National Institutes of Health, 6120
Executive Blvd., Suite 300, Rockville, MD
20852, (Telephone Conference Call).
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Contact Person: Sheila A. Prindiville, MD,
MPH, Director, Coordinating Center for
Clinical Trials, Office of the Director,
National Cancer Institute, National Institutes
of Health, 6120 Executive Blvd., 3rd Floor
Suite, Bethesda, MD 20892, 301–451–5048,
prindivs@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ctac/ctac.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 17, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–01330 Filed 1–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Population
Sciences and Epidemiology.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
E:\FR\FM\24JAN1.SGM
24JAN1
]]>Agencies
[Federal Register Volume 78, Number 16 (Thursday, January 24, 2013)]
[Notices]
[Page 5190]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01327]
[[Page 5190]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, National Advisory Neurological
Disorders and Stroke.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in sections 552b(c)(6), Title
5 U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Neurological Disorders and Stroke, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Institute of Neurological Disorders and Stroke.
Date: February 24-26, 2013.
Time: 7:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Natcher Building,
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Alan P. Koretsky, Ph.D., Scientific Director,
Division of Intramural Research, National Institute of Neurological
Disorders and Stroke, NIH, 35 Convent Drive, Room 6A908, Bethesda,
MD 20892, (301) 435-2232, koretskya@ninds.nih.gov
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS).
Dated: January 17, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-01327 Filed 1-23-13; 8:45 am]
BILLING CODE 4140-01-P
